De Luca, G. Et Al. 2021. Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic.. Diabetes epidemiology and management , vol.4 , 100022.

De Luca, G., Nardin, M., Algowhary, M., Uguz, B., Oliveira, D. C., Ganyukov, V., ... Zimbakov, Z.(2021). Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic.. Diabetes epidemiology and management , vol.4, 100022.

De Luca, Giuseppe Et Al. "Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic.," Diabetes epidemiology and management , vol.4, 100022, 2021

De Luca, Giuseppe D. Et Al. "Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic.." Diabetes epidemiology and management , vol.4, pp.100022, 2021

De Luca, G. Et Al. (2021) . "Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic.." Diabetes epidemiology and management , vol.4, p.100022.

@article{article, author={Giuseppe De Luca Et Al. }, title={Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic.}, journal={Diabetes epidemiology and management}, year=2021, pages={100022} }